| NCT Number | NCT07478848 |
| Lead Sponsor | Abramson Cancer Center at Penn Medicine
Collaborators: National Cancer Institute (NCI) |
| Conditions | Large B Cell Lymphoma, Non Hodgkin Lymphoma (NHL), Diffuse Large B Cell Lymphoma (DLBCL), Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B Cell Lymphoma Relapsed |
| Enrollment | 14 participants |
| Start Date | 2026-05-29 |
| Primary Completion | 2029-01-01 (estimated) |
| Study Completion | 2029-01-01 (estimated) |
| Updated on ClinicalTrials.gov | 2026-07-01 |